Category 2
Funding boost to accelerate AI innovation in women’s health

Agentic AI platform Ema has raised US$3m to accelerate AI innovation in women’s health.
Ema has been trained on a proprietary dataset of 10 million interactions between women and
physicians discussing health and wellness together.
Made by women for women’s health, the platform has been clinically-vetted to deliver personalised care and help women make informed decisions about their health.
La Keisha Landrum Pierre, managing partner at investor Emmeline Ventures, said: “We invested in Ema because they are redefining women’s health with a powerful combination of empathy and technology.
“Ema goes beyond generative AI, offering a trusted partner that understands women’s unique needs. By harnessing clinically sound AI, Ema empowers women (and their families) along with their clinical providers to achieve better outcomes, reshaping how care is delivered for a healthier, happier, and more empowered future.”
The funding is a precursor to Ema’s anticipated nextround which will fuel continued AI innovation and support of their enterprise clients like such as PatientsLikeMe and Willow.
“Ema has proven its ability to significantly advance women’s health,” said Amanda Ducach, CEO of
Ema.
“As an example, in perinatal mental health conversations, an impressive 75 per cent of women who took
the EPDS depression assessment through Ema sought professional mental health support by booking
appointments.
“Moreover, 34 per cent of women engaging with Ema during the campaign displayed signs of
depression, highlighting the critical need for accessible mental health resources. Our platform’s ability to
foster meaningful engagement and connect women to care underscores its transformative impact in
addressing mental health challenges on a broad scale.”
News
WEC Chair calls out Health Minister’s delay on banning BBLs and other harmful cosmetic procedures

WEC chair Sarah Owen has criticised delays over a ban on high harm cosmetic procedures, including liquid BBLs.
The Women and Equalities Committee has published a letter from health minister Karin Smyth after the government missed the 18 April deadline to respond to the committee’s report on cosmetic procedures.
The report, published on 18 February, recommended that high harm procedures such as liquid Brazilian butt lifts, known as BBLs, should be banned immediately without further consultation.
MPs said the government is “not moving quickly enough” in introducing a licensing system for non-surgical cosmetic procedures and “should accelerate regulatory action”.
They also warned that “this lack of timely action is fostering complacency in self-regulation” within the industry.
In her letter, Smyth said the Department of Health and Social Care had “taken the decision to first of all focus on introducing legal safeguards for the cosmetic procedures posing the highest risks and I can confirm that we plan to consult on draft regulations in June”.
The letter added:
“Our intention is to issue a formal government response to the WEC report, once our consultation setting out our proposed approach and underpinning legislation is published.
“I acknowledge the concerns around the government’s pace of delivery in this area but, as you will appreciate, this is a complex area of policy and striking the balance between increased patient safety, placing new requirements on businesses and introducing proportionate and enforceable regulation is challenging.
“I recognise that regulation has not kept pace with the expansion of the aesthetics industry and, on that basis, I can assure you that we are committed to implementing licensing in the current parliament.”
Owen, chair of the Women and Equalities Committee and Labour MP, said:
“Further consultation and delay on clamping down on high harm procedures such as liquid BBLs is unacceptable. It allows unscrupulous people to continue to put women at risk and lets down those who have lost loved ones following these practices or who have come to serious harm themselves.
“As WEC’s report warned back in February, procedures that are deemed high risk such as liquid BBLs and liquid breast augmentations, which have already been shown to pose a serious threat to patient safety, should be banned immediately.
“While it is positive to hear a licensing system for non-surgical cosmetic procedures will be introduced within this Parliament, this issue requires faster regulatory progress, particularly in high harm areas, and the Government is not moving quickly enough.
“The Committee previously heard a powerful and shocking testimony from a woman who developed sepsis after having a liquid BBL. Her experience and those of many others provides clear evidence of the need to tackle this evolving wild west.”
A liquid BBL is a non-surgical procedure intended to alter the shape of the buttocks.
Sepsis is a potentially life-threatening response to infection that can lead to organ damage if not treated quickly.
Pregnancy
Hinge charts pelvic pain breakthrough in latest trial

A women’s health intervention that harnesses software, AI and wearables to address pelvic pain, as well as depression, has shown promising results.
Hinge Health’s digital ‘Women’s Pelvic Health Programme’ has reported a 44 per cent reduction in pelvic pain after four weeks of use – and 53 per cent after 12 weeks.
The probability of the intervention group screening for moderate to severe depression was significantly lower by 11 per cent compared to the control group.
Bijal Toprani, pelvic health physical therapist at Hinge Health and co-author of the study, said: “Although women’s pelvic pain is incredibly common, it remains undertreated and as a result, many women are going about their lives suffering in silence.
“This study builds on validated research supporting the efficacy of Hinge Health’s Women’s Pelvic Health program to make a tangible impact for women and improve their quality of life.”
The findings were published in the medical journal, BMC Women’s Health.
One in three women will suffer a pelvic floor disorder in their lifetime.
These disorders occur when pelvic floor muscles become weak or tight. Women with chronic pelvic pain experience a wide range of physical and psychological challenges related to their condition, from urinary urgency and constipation to lower back and hip pain.
Some common causes are muscle strain during pregnancy, trauma or injury to the pelvic floor from surgery or childbirth, hormonal changes with menopause, and stress or anxiety triggering tension in the pelvic floor.
This pain can take a toll on a woman’s overall wellbeing, impacting both their personal and professional lives.
In addition to a lack of awareness around pelvic health issues, inadequate access to pelvic floor specialists makes it difficult for women to find care, making digital solutions essential.
Hinge Health’s 2025 State of MSK Care Report found that while it can take an average of 93 days to see a pelvic floor physical therapist (PT) in person.
“Pelvic floor problems are treatable, however, a major problem is simply access to specialists,” said Dr. Jeff Krauss, CMO at Hinge Health.
“This study is an achievement demonstrating the strengths of our digital Women’s Pelvic Health Program and sends an encouraging message to women that there are clinically-validated, easily-accessible programmes available to help them.”
This observational study examined pain, depression, and anxiety outcomes at four and 12 weeks among participants of a digital women’s pelvic health program compared to a non-participant group. A total of 797 participants were included in the sample.
The company is headquartered in San Francisco.
Category 2
New Visa programme could boost femtech founders amid investment gap

Femtech startups may be able to access a new investment scheme from Visa, which aims to close the funding gap experienced by female founders.
Visa Foundaton has launched the CatalyseHer Programme in the UK and is aiming to provide 500 women entrepreneurs with training and fundraising support to grow their businesses and make them more attractive to investors.
The programme includes training, networking and micro-grants and is aimed at early stage, women-owned businesses.
It is seeking to 500 UK-based female founders to address the gender financing gap facing women entrepreneurs in the UK.
Women entrepreneurs still face barriers when it comes to access to the investments and resources that support innovation.
Women-founded businesses in the UK receive only a two per cent share of total venture capital investments according to the British Business Bank.
Najada Kumbuli, head of investments and partnerships, Visa Foundation said: “Women entrepreneurs play a crucial role in all economies by driving innovation and impact at scale.
“This programme aims to address the main challenges faced by women entrepreneurs and create a ripple effect across many communities in the UK.”
Mandy Lamb, MD in the UK and Ireland at Visa, said: “Women entrepreneurs are critical in developing a more sustainable, equitable future. By addressing barriers and providing access to resources such as funding, mentorship and networking, Visa Foundation can help unlock the potential of women-led businesses to drive further innovation in the UK.”
CatalyseHer is supported by the social enterprise IMCO. See more on the programme here.
Visa also runs the ‘She’s Next’ programme, a global initiative to spotlight women in their efforts to fund, run, and grow their businesses.
Launched in January 2019, it has invested £2.5+m in grants and coaching for female business owners across Europe.
Entrepreneur2 weeks agoFertility startup American Baby Company secures US$4m
Fertility1 week agoNatural Cycles receives sixth FDA clearance for fertility algorithm
Wellness2 weeks agoAstraZeneca drug approved for breast cancer in EU
Wellness4 days agoCancer patient receives ‘landmark’ treatment in world-first
Hormonal health2 weeks agoType 2 diabetes rising among young women, experts warn
Insight1 week agoExperimental treatment significantly slows progression of fatal brain disease in women, study finds
Sponsored Content1 week agoThe room is filling up at WHW Europe 2026 with super early bird pricing ending this Friday
Insight1 week agoJohnson & Johnson offers to pay US$5.5bn to settle talc cancer lawsuits











